Procyon Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.74M | Sell |
17,212
-1,517
| -8% | -$418K | 0.44% | 50 |
|
|
2025
Q1 | $4.97M | Buy |
18,729
+777
| +4% | +$206K | 0.3% | 77 |
|
|
2024
Q4 | $4.17M | Sell |
17,952
-2,607
| -13% | -$605K | 0.26% | 85 |
|
|
2024
Q3 | $4.54M | Sell |
20,559
-1,334
| -6% | -$294K | 0.31% | 77 |
|
|
2024
Q2 | $4.3M | Buy |
21,893
+1,452
| +7% | +$285K | 0.32% | 71 |
|
|
2024
Q1 | $4.4M | Sell |
20,441
-522
| -2% | -$112K | 0.34% | 68 |
|
|
2023
Q4 | $4.41M | Buy |
20,963
+4,679
| +29% | +$985K | 0.38% | 60 |
|
|
2023
Q3 | $3.26M | Sell |
16,284
-1,061
| -6% | -$212K | 0.33% | 72 |
|
|
2023
Q2 | $3.21M | Buy |
17,345
+3,008
| +21% | +$557K | 0.4% | 58 |
|
|
2023
Q1 | $2.75M | Buy |
14,337
+4,348
| +44% | +$833K | 0.46% | 48 |
|
|
2022
Q4 | $1.68M | Buy |
9,989
+4,490
| +82% | +$755K | 0.31% | 76 |
|
|
2022
Q3 | $974K | Buy |
5,499
+889
| +19% | +$157K | 0.24% | 97 |
|
|
2022
Q2 | $944K | Buy |
4,610
+517
| +13% | +$106K | 0.21% | 104 |
|
|
2022
Q1 | $973K | Buy |
4,093
+759
| +23% | +$180K | 0.2% | 103 |
|
|
2021
Q4 | $762K | Buy |
3,334
+1,506
| +82% | +$344K | 0.16% | 125 |
|
|
2021
Q3 | $354K | Buy |
1,828
+142
| +8% | +$27.5K | 0.09% | 203 |
|
|
2021
Q2 | $359K | Buy |
1,686
+384
| +29% | +$81.8K | 0.1% | 179 |
|
|
2021
Q1 | $266K | Buy |
1,302
+203
| +18% | +$41.5K | 0.12% | 188 |
|
|
2020
Q4 | $200K | Buy |
+1,099
| New | +$200K | 0.1% | 215 |
|
|
2020
Q3 | – | Sell |
-1,016
| Closed | -$165K | – | 349 |
|
|
2020
Q2 | $165K | Sell |
1,016
-181
| -15% | -$29.4K | 0.09% | 211 |
|
|
2020
Q1 | $207K | Sell |
1,197
-1,603
| -57% | -$277K | 0.14% | 145 |
|
|
2019
Q4 | $562K | Buy |
+2,800
| New | +$562K | 0.34% | 69 |
|